发明名称 Metabolite
摘要 A method of treating anxiety, agitation, hostility, panic, eating disorders, affective symptoms, mood symptoms, negative and positive psychotic symptoms commonly associated with schizophrenia, dementia, anxiety, depression, mood disorders, bipolar disorders, bipolar mania, bipolar depression, cognitive disorders and neurodegenerative disorders comprising administering an effective amount of Formula I or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of Formula I or its pharmaceutically acceptable salt and at least on pharmaceutically acceptable carrier or diluent.
申请公布号 US2005026900(A1) 申请公布日期 2005.02.03
申请号 US20040883024 申请日期 2004.07.01
申请人 GOLDSTEIN JEFFREY 发明人 GOLDSTEIN JEFFREY
分类号 A61K31/554;A61P25/18;(IPC1-7):A61K31/554 主分类号 A61K31/554
代理机构 代理人
主权项
地址